Back
Common Mechanism Performance
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Relevant to AI biosecurity governance: as AI tools lower barriers to bioweapon design, screening tools like the Common Mechanism represent a technical safeguard layer; this page documents its validated performance metrics.
Metadata
Importance: 52/100organizational reportreference
Summary
IBBIS presents performance testing results for the Common Mechanism, a free open-source biosecurity tool for screening synthetic DNA/RNA sequences. Testing demonstrated <2% false positive rates, compliance with industry best practices (validated by Twist Bioscience), and resilience to AI-generated evasion attempts, positioning it as a viable global standard for biosecurity screening.
Key Points
- •Free, open-source sequence screening tool launched May 2024, designed to flag dangerous nucleic acid sequences without excessive false alarms
- •Beta testing with Twist Bioscience and other synthesis providers confirmed compliance with industry best practices including IGSC Harmonized Screening Protocol
- •Achieved <2% false positive rate on real synthetic biology designs, minimizing disruption to legitimate research orders
- •Performance benchmarked as on par with existing commercial industry screening tools in standardized test sets
- •Demonstrated resilience against AI-generated sequence challenges, relevant to biosecurity risks from AI-assisted biodesign
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20265 KB
Common Mechanism | Sequence Screening Performance - IBBIS
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
Common Mechanism | Sequence Screening Performance
Testing v0.1 of the Common Mechanism
The Common Mechanism is a free, open-source, globally-available tool for synthesis screening. Our automated software for screening sequences of nucleic acids (including DNA and RNA) was shown to sensitively flag sequences of concern without raising unnecessary alarms.
This page describes the results of testing done before the release of version 0.1 of the Common Mechanism sequence screening package . Before the launch of the software in May 2024 , our testing showed:
Compliance with industry best practices when tested against real order customer streams by beta testers such as Twist Bioscience
<2% false positive flags of real synthetic biology designs
Performance on par with industry screening tools in a standard test set
Resilience to AI-generated challenges
Detailed Performance Information
Below, you will find a summary of test results from our beta testing by synthesis providers and internal testing of the software prior to the version 0.1 release.
Compliance with best industry practices
Twist Bioscience ran a series of real customer orders through the Common Mechanism, finding that the tool would allow users to screen their orders in compliance with industry best practices .
A number of other synthesis providers, including benchtop manufacturers, academic biofoundries, and smaller synthesis companies were engaged to install and test the tool during the beta testing process.
The Common Mechanism is designed to meet and exceed current screening guidance, such as the IGSC Harmonized Screening Protocol and U.S. Framework for Nucleic Acid Synthesis Screening . IBBIS is a member of the International Gene Synthesis Consortium and an active participant in efforts to standardize best practices for synthesis screening, such as through ongoing engagements with EBRC and NIST .
<2% false positive flags of real synthetic biology designs
The Common Mechanism was run against the iGEM Registry of Standard Biological Parts , a public database capturing over 20,000 biological parts used to build synthetic biology devices and systems. Teams participating in the international iGEM Competition submit the biological parts designed for their projects to the Regis
... (truncated, 5 KB total)Resource ID:
ea1a2d738f5d52a2 | Stable ID: sid_8sBizYVYQq